Theravance Biopharma
TBPH • NASDAQ • Stock Fundamentals
Theravance Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rick E. Winningham, with a market cap of $850.1M.
Market Cap$850.1M
Employees99.0
CEORick E. Winningham
CountryCayman Islands
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Theravance Biopharma FAQ
Common questions about Theravance Biopharma
Theravance Biopharma (TBPH) has a market capitalization of $850.1M and trades on NASDAQ.
Theravance Biopharma has approximately 99 employees.